Lv3
250 积分 2023-04-30 加入
Risk factors, clinical features and treatment of Behçet's disease uveitis
14天前
已完结
A rare simultaneous presentation of combined occlusion and optic neuritis in a lupus erythematosus patient with anti-phospholipid antibody syndrome
14天前
已完结
Myelin Oligodendrocyte Glycoprotein–Associated Disease Optic Neuritis With Concurrent Combined Central Retinal Artery and Vein Occlusion
14天前
已关闭
International consensuses and guidelines on managing ocular Behçet’s disease by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), the Asia-Pacific Vitreo-Retina Society (APVRS), the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII) and the Academia Retina Internationalis (ARI)
14天前
已完结
Comparison between intravitreal brolucizumab and aflibercept in the treatment-naive central involved diabetic macular edema: One-year real-life case series
21天前
已完结
The effect of brolucizumab on diabetic macular edema and ischemia; a real-world analysis
26天前
已完结
The effect of brolucizumab on diabetic macular edema and ischemia; a real-world analysis
1个月前
已完结
Anti-VEGF Treatment Strategies for 3 Subtypes of Neovascular Age-Related Macular Degeneration in a Clinical Setting
2个月前
已关闭
Real-World 1-Year Outcomes of Treatment-Intensive Neovascular Age-Related Macular Degeneration Switched to Faricimab
2个月前
已关闭
Diabetic macular edema treated with ranibizumab following bevacizumab failure in Israel (DERBI study)
2个月前
已完结
皖公网安备34019202002308
